Dr. Rashmita Tiga¹, Prof. (Dr.) Pragya P. Mallik², Dr. Snehamayee Mishra³, Dr. Bharatilata Acharya⁴

¹MD Scholar,P.G Department of Kayachikitsa ,Gopabandhu Ayurveda Mahavidyalaya, Puri, Odisha.

²Professor & HOD, P.G Department of Kayachikitsa, Gopabandhu Ayurveda Mahavidyalaya, Puri, Odisha.

³HOD, P.G Department of Kayachikitsa, National College of Ayurveda, Barwala, Hisar, Haryana.

⁴Assistant Professor, P.G Department of Kayachikitsa, Gopabandhu Ayurveda Mahavidyalaya, Puri, Odisha.

http://dx.doi.org/10.47191/ijahm/v14i6.04

ABSTRACT:In Ayurveda, the treatment of Chronic Kidney Disease (CKD) is approached through a holistic lens, where the focus lies not just on alleviating symptoms but also on restoring balance to the body’s intricate systems. Pashanabhedadi Kwatha, a revered polyherbal formulation, exemplifies this Ayurvedic approach by combining a unique blend of herbs (such as Pashanabheda, Yastimadhu, Vasa, Gokshura, Eranda, Aragwadha phala majja, Pippali, Ela, Shilajit, Souvarchala lavana, and Mishri), each chosen for its specific role in supporting kidney health, also known for their diuretic, anti-inflammatory, and detoxifying properties. When combined, they work synergistically to enhance renal function, regulate fluid balance, and reduce inflammation, which are crucial factors in managing CKD. In Ayurveda, kidney dysfunction is often attributed to imbalances in the doshas, accumulation of ama and disturbances in agni and srotas. Pashanabhedadi Kwatha is formulated to address these imbalances, with its herbs targeting specific physiological processes that support renal and metabolic health. The present study aims to evaluate the effects of Pashanabhedadi Kwatha on CKD through the lens of Ayurvedic principles like Rasa Panchaka, and to explore its influence on doshic imbalances, ama, agni, srotas, and the specific phytochemical constituents responsible for its therapeutic benefits. By reviewing both classical and modern literature, this study seeks to shed light on the potential mechanisms behind its beneficial effects in CKD and offer insights into its clinical applications.

KEYWORD :Ayurveda, Chronic Kidney Disease, Pashanabhedadi Kwatha, Rasa Panchaka.

REFERENCES:

1. Mishra Siddhi Nandan,Bhaisajya Ratnavali of Kaviraj Govind Das Sen,Ch-34/25, Chaukhamba Surbharti Prakashan,Varanasi.
2. Pashanabheda: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:754-75; D.G.V by Prof. P.V Sharma Vol-2, Pg no: 650-652.
3. Yastimadhu: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:152-156; D.G.V by Prof. P.V Sharma Vol-2, Pg no: 253-256, API Vol-1, Pg no:215-217.
4. Vasa: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:407-410; D.G.V by Prof. P.V Sharma Vol-2, Pg no: 241-244, API Vol-1, Pg no:207-208.
5. Gokshura: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:98-102; D.G.V by Prof. P.V Sharma Vol-2, Pg no: 632-634, API Vol-1, Pg no:64-66.
6. Eranda: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:483-487; D.G.V by Prof. P.V Sharma Vol-2, Pg no: 58-62, API Vol-1, Pg no:58-60.
7. Aragwadha: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:200-204; D.G.V by Prof. P.V Sharma Vol-2, Pg no: 170-173, API Vol-1,Pg no:12-14.
8. Pippali: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:452-458; D.G.V by Prof. P.V Sharma Vol-2, Pg no: 275-279, API Vol-4.
9. Shilajit: Shastri Kashinath Pt.,Chaturvedi Gorakha Natha, Chaukhamba Bharati Academy,Varanasi,Vidyotini Hindi Commentary, Charak Samhita Chikitsa Sthana Ch-1.3.
10. Ela: D.G.V by Dr. J.L.N Shastry Vol-2, Pg no:527-530; D.G.V by Prof. P.V Sharma Vol-2, Pg no:719-721.
11. Souvarchala lavana: D.G.V by Dr. J.L.N Shastry Vol-3, Pg no:79; D.G.V by Prof. P.V Sharma Vol-3, Pg no: 650-652.
12. Chitranjan Das et al. A Literary Review and Therapeutic Action of Pashanbheda, JAIMS,Vol-7, July 2022.
13. Gurav & Gurav, IJPSR, 2014; Vol. 5(5): 1630-1642.
14. Damle Monica, International Journal of Herbal Medicine 2014; 2(2): 132-136.
15. Ambreen Shoaib / An ethnobotanical review of Adhatoda vasica, 2021, 67(4): 248-263.
16. Chhatre S, Nesari T, Somani G, Kanchan D, Sathaye S. Phytopharmacological overview of Tribulus terrestris. Phcog Rev 2014;8:45‑51.
17. Asian Pacific Journal of Tropical Medicine 11(3):p 177-185, March 2018.
18. Rahmani AH. Cassia fistula Linn: Potential candidate in the health management. Phcog Res 2015;7:217-24.
19. IJPSRR, Volume 5, Issue 1, November – December 2010.
20. R. Kiran et al., Review; Chemical Characteristics and Therapeutic Potential of Asphaltum Punjabianum (Shilajit),2019.
21. Kumar and Kumar, IJPSR, 2021; Vol. 12(8): 4122-4131.
22. Mestry et al., World Journal of Pharmaceutical Research, 2024.
23. Richet and M. Martin, Med. Record. XXI, 394